RNS Number : 6770O
BioPharma Credit PLC
11 October 2021
BioPharma Credit PLC (the "Company")
Director Declaration
In accordance with Listing Rule 9.6.14 R, the Company has been informed by Harry Hyman that TMT Acquisition PLC, a company where he was appointed as chairman and non-executive director on 25 March 2021, has today been listed on the Official List of the UK Listing Authority and admitted to trading on the Main Market of the London Stock Exchange.
11 October 2021
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.